AVANIR PHARMACEUTICALS INC - CL A NEW (AVNR)

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / CL A NEW
Total 13F shares
93,740,810
Share change
+524,864
Total reported value
$343,509,647
Put/Call ratio
28%
Price per share
$3.67
Number of holders
98
Value change
+$2,664,816
Number of buys
52
Number of sells
48

Institutional Holders of AVANIR PHARMACEUTICALS INC - CL A NEW (AVNR) as of Q1 2014

As of 31 Mar 2014, AVANIR PHARMACEUTICALS INC - CL A NEW (AVNR) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 93,740,810 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, BlackRock Fund Advisors, State Street Corp, BAKER BROS. ADVISORS LP, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, TimesSquare Capital Management, LLC, WELLINGTON MANAGEMENT CO LLP, and MILLENNIUM MANAGEMENT LLC. This page lists 98 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.